PL3091005T3 - Pochodna 1,2-naftochinonu i sposób jej wytwarzania - Google Patents
Pochodna 1,2-naftochinonu i sposób jej wytwarzaniaInfo
- Publication number
- PL3091005T3 PL3091005T3 PL14877254T PL14877254T PL3091005T3 PL 3091005 T3 PL3091005 T3 PL 3091005T3 PL 14877254 T PL14877254 T PL 14877254T PL 14877254 T PL14877254 T PL 14877254T PL 3091005 T3 PL3091005 T3 PL 3091005T3
- Authority
- PL
- Poland
- Prior art keywords
- preparing same
- naphthoquinone derivative
- naphthoquinone
- derivative
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/60—Naphthoxazoles; Hydrogenated naphthoxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130166912 | 2013-12-30 | ||
PCT/KR2014/013038 WO2015102369A1 (ko) | 2013-12-30 | 2014-12-30 | 1,2 나프토퀴논 유도체 및 이의 제조방법 |
EP14877254.4A EP3091005B1 (en) | 2013-12-30 | 2014-12-30 | 1,2-naphthoquinone derivative and method for preparing same |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3091005T3 true PL3091005T3 (pl) | 2021-04-19 |
Family
ID=53493651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL14877254T PL3091005T3 (pl) | 2013-12-30 | 2014-12-30 | Pochodna 1,2-naftochinonu i sposób jej wytwarzania |
Country Status (10)
Country | Link |
---|---|
US (1) | US10927085B2 (pl) |
EP (1) | EP3091005B1 (pl) |
JP (1) | JP6903266B2 (pl) |
KR (1) | KR101739362B1 (pl) |
CN (1) | CN106103417B (pl) |
AU (1) | AU2014374601B2 (pl) |
CA (1) | CA2935319C (pl) |
DK (1) | DK3091005T3 (pl) |
PL (1) | PL3091005T3 (pl) |
WO (1) | WO2015102369A1 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105130936B (zh) * | 2015-09-01 | 2017-09-26 | 中国药科大学 | 一类邻萘醌化合物、其制备方法和医药用途 |
US11717511B2 (en) | 2018-04-09 | 2023-08-08 | Huen Co., Ltd. | Pharmaceutical composition comprising derivative compound of 1,2-naphthoquinone for preventing or treating solid cancer or blood cancer |
KR20190118118A (ko) | 2018-04-09 | 2019-10-17 | 영진약품 주식회사 | 1,2-나프토퀴논 유도체 화합물을 포함하는 고형암 또는 혈액암의 예방 또는 치료용 약학 조성물 |
KR102247694B1 (ko) | 2019-05-31 | 2021-05-03 | 주식회사 엘마이토테라퓨틱스 | 나프토퀴논 또는 벤조인다졸 화합물을 유효성분으로 포함하는 염증성 질환 치료용 약학적 조성물 |
CN111559991B (zh) * | 2020-06-01 | 2022-01-25 | 河南省锐达医药科技有限公司 | 一种萘胺类化合物及其盐的制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080047959A (ko) * | 2006-11-27 | 2008-05-30 | 주식회사 엠디바이오알파 | 비만, 당뇨, 대사성 질환, 퇴행성 질환 및 미토콘드리아이상 질환의 치료 또는 예방을 위한 나프토퀴논계 약제조성물 |
KR101468449B1 (ko) * | 2007-04-26 | 2014-12-04 | 주식회사 케이티앤지생명과학 | 신규한 페난스렌퀴논계 화합물 및 이를 포함하는대사증후군 질환의 치료 또는 예방용 약제 조성물 |
-
2014
- 2014-12-30 WO PCT/KR2014/013038 patent/WO2015102369A1/ko active Application Filing
- 2014-12-30 US US15/102,974 patent/US10927085B2/en active Active
- 2014-12-30 AU AU2014374601A patent/AU2014374601B2/en active Active
- 2014-12-30 PL PL14877254T patent/PL3091005T3/pl unknown
- 2014-12-30 JP JP2016544574A patent/JP6903266B2/ja active Active
- 2014-12-30 CN CN201480071786.4A patent/CN106103417B/zh active Active
- 2014-12-30 EP EP14877254.4A patent/EP3091005B1/en active Active
- 2014-12-30 DK DK14877254.4T patent/DK3091005T3/da active
- 2014-12-30 CA CA2935319A patent/CA2935319C/en active Active
- 2014-12-30 KR KR1020140193306A patent/KR101739362B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2935319A1 (en) | 2015-07-09 |
EP3091005B1 (en) | 2020-11-11 |
US20160376243A1 (en) | 2016-12-29 |
CA2935319C (en) | 2022-07-19 |
KR20150080425A (ko) | 2015-07-09 |
JP6903266B2 (ja) | 2021-07-14 |
EP3091005A4 (en) | 2017-05-17 |
WO2015102369A1 (ko) | 2015-07-09 |
US10927085B2 (en) | 2021-02-23 |
AU2014374601B2 (en) | 2019-05-23 |
EP3091005A1 (en) | 2016-11-09 |
CN106103417B (zh) | 2019-08-06 |
AU2014374601A1 (en) | 2016-06-30 |
KR101739362B1 (ko) | 2017-06-09 |
DK3091005T3 (da) | 2020-12-21 |
CN106103417A (zh) | 2016-11-09 |
JP2017501204A (ja) | 2017-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201604328B (en) | 1,2-naphthoquinone derivative and method for preparing same | |
EP3006415A4 (en) | PROCESS FOR PRODUCING NANOCEMENT AND NANOCEMENT | |
IL241046A0 (en) | Fertilizer composition and method for its preparation | |
EP2995281A4 (en) | STENT, METHOD FOR THE PRODUCTION THEREOF AND DEVICE FOR THE PRODUCTION THEREOF | |
EP2962752A4 (en) | VESICLE CONTAINING A SUBSTANCE, AND PROCESS FOR PRODUCING THE SAME | |
GB201406038D0 (en) | Autotroph-based deodorizer and method for manufacturing the same | |
HK1205214A1 (zh) | 鑽土設備及鑽土方法 | |
EP3017149A4 (en) | WEARING SURFACE AND METHOD FOR MANUFACTURING THE SAME | |
EP3032307A4 (en) | Imaging device, imaging method and program | |
IL242437B (en) | Compound 9, 5-dimethyl-9-hydroxy-decan-4-al, its use and its preparation process | |
ZA201601343B (en) | Vancomycin derivative, and preparation method and application thereof | |
EP2946002A4 (en) | LUBRICANT COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF | |
EP3040754A4 (en) | Imaging device, method, and program | |
EP3001465A4 (en) | Light-emitting element and method for preparing same | |
PL3068728T3 (pl) | Domieszkowany hydroksy-fosforan miedzi II, sposób jego wytwarzania i stosowania | |
PL3091005T3 (pl) | Pochodna 1,2-naftochinonu i sposób jej wytwarzania | |
EP2978011A4 (en) | PROCESS FOR PREPARING A COMPLEX AND COMPOSITION | |
GB201305947D0 (en) | New method 1 | |
EP2952519A4 (en) | PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF | |
EP3041217A4 (en) | Imaging device, method and program | |
SG11201507951SA (en) | Method for producing 2,7-octadien-1-ol | |
ZA201602129B (en) | Audiometry system and method | |
EP3052484A4 (en) | Sulfonylindole derivatives and method for preparing the same | |
HUE037141T2 (hu) | Eljárás 1,1-dibróm-1-fluoretán elõállítására | |
EP2987794A4 (en) | VINBLASTINE DERIVATIVES, PROCESS FOR THEIR SYNTHESIS AND THEIR APPLICATION |